Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Clinical trial NCT00002723 · COMPLETED

Trial details

NCT number: NCT00002723
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 1996-01-01
Primary completion: 2002-08-01
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.